HOB Biotech Group Corp.,Ltd (SHA:688656)
China · Delayed Price · Currency is CNY 118.57
-3.38 (-2.77%)
Sep 11, 2026, 3:00 PM CST
SHA:688656 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 404.51 | 398.4 | 402.34 | 394.41 | 320.39 | 317.71 |
Revenue Growth | 3.94% | -0.98% | 2.01% | 23.10% | 0.84% | 43.20% |
Gross Profit Gross Profit Growth | 238.66 | 232.78 | 257.18 | 244.99 | 202.26 | 219.16 |
Operating Income Operating Income Growth | 22.26 | 17.67 | 44.16 | 53.3 | 42.01 | 84.33 |
Net Income Net Income Growth | 27.71 | 23.2 | 36.8 | 47.33 | 41.65 | 86.19 |
Earnings Per Share EPS Growth | 0.45 | 0.37 | 0.58 | 0.74 | 0.66 | 1.40 |
EPS Growth | -0.24% | -36.21% | -21.62% | 12.12% | -52.86% | 16.67% |
| Fiscal Year | FY 2025 |
|---|---|
| Period Ending | Dec '25 Dec 31, 2025 |
Allergy Detection Reagent Allergy Detection Reagent Growth | 202.63 |
Autoimmune Reagents Products Autoimmune Reagents Products Growth | 145.94 |
Instrument Business Instrument Business Growth | 22.18 |
Others Others Growth | 18.44 |
Total Total Growth | 389.19 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 64.86 | 63.34 | 121.63 | 163.47 | 289.03 | 454.87 |
Total Debt Total Debt Growth | 32.07 | 47.39 | 115.69 | 55.86 | 65.43 | 30.88 |
Net Cash (Debt) Net Cash Growth | 32.79 | 15.95 | 5.93 | 107.61 | 223.6 | 423.99 |
Net Cash Growth | - | 168.84% | -94.49% | -51.88% | -47.26% | 2762.22% |
Net Cash Per Share Net Cash Per Share Growth | 0.53 | 0.25 | 0.09 | 1.68 | 3.54 | 6.89 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 86.95 | 72.94 | 101.22 | 102.69 | 58.31 | 104.79 |
Capital Expenditures CapEx Growth | -31.57 | -73.9 | -155.37 | -178.03 | -220.21 | -167.89 |
Free Cash Flow Free Cash Flow Growth | 55.38 | -0.96 | -54.15 | -75.34 | -161.9 | -63.09 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 59.00% | 58.43% | 63.92% | 62.12% | 63.13% | 68.98% |
Operating Margin | 5.50% | 4.44% | 10.98% | 13.51% | 13.11% | 26.54% |
Pretax Margin | 7.37% | 6.23% | 10.20% | 14.36% | 14.51% | 31.20% |
Profit Margin | 6.85% | 5.82% | 9.15% | 12.00% | 13.00% | 27.13% |
FCF Margin | 13.69% | -0.24% | -13.46% | -19.10% | -50.53% | -19.86% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.200 | 0.200 | 0.300 | 0.400 | 0.300 | 0.530 |
Dividend Per Share Growth | -33.33% | -33.33% | -25.00% | 33.33% | -43.40% | 76.67% |
Dividend Yield | 0.19% | 0.13% | 0.32% | 1.18% | 0.92% | 0.88% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 263.44 | 415.50 | 161.55 | 46.31 | 50.75 | 46.09 |
PS Ratio | 18.38 | 24.20 | 14.78 | 5.56 | 6.60 | 12.50 |